Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.7K
Mutations01:39

Mutations

90.0K
Overview
90.0K
Mutations01:35

Mutations

41.7K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
41.7K
Exon Recombination02:32

Exon Recombination

3.8K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
3.8K
The Ras Gene02:38

The Ras Gene

6.7K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of the Omega Subzone in Determining the Membership of a Protein in One of the Two Families of the LexA/Signal Peptidase-like Superfamily.

International journal of molecular sciences·2026
Same author

Database of recurrent mutations, an unbiased web resource to browse recurrent mutations in cancers.

iScience·2026
Same author

Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germ line ERCC6L2 disease.

Blood·2026
Same author

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies.

Molecular oncology·2025
Same author

The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis.

Leukemia·2025
Same author

Complement components C1r and C1s promote oral squamous cell carcinoma cell proliferation.

Journal of oral biosciences·2025

Related Experiment Video

Updated: Nov 10, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

8.9K

Structural Basis for the Functional Changes by EGFR Exon 20 Insertion Mutations.

Mahlet Z Tamirat1, Kari J Kurppa2, Klaus Elenius2,3,4

  • 1Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, 20520 Turku, Finland.

Cancers
|April 3, 2021
PubMed
Summary
This summary is machine-generated.

Epidermal growth factor receptor (EGFR) exon 20 insertions in non-small cell lung cancer (NSCLC) stabilize the active conformation and disrupt the inactive state. These structural changes may explain tyrosine kinase inhibitor (TKI) resistance in NSCLC patients.

Keywords:
EGFR tyrosine kinaseexon 20 insertion mutationsmolecular dynamics simulationnon-small cell lung cancerstructural biology

More Related Videos

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
10:57

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

Published on: August 14, 2018

10.9K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.9K

Related Experiment Videos

Last Updated: Nov 10, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

8.9K
Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
10:57

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

Published on: August 14, 2018

10.9K
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.9K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Activating somatic mutations in the epidermal growth factor receptor (EGFR) are key drivers in non-small cell lung cancer (NSCLC).
  • While EGFR L858R and exon 19 deletions are common, exon 20 insertions represent a distinct mutation class in NSCLC.
  • These exon 20 insertion mutations are associated with intrinsic resistance to standard EGFR tyrosine kinase inhibitors (TKIs).

Purpose of the Study:

  • To investigate the structural and dynamic consequences of common EGFR exon 20 insertions (V769insASV and D770insNPG) within the EGFR kinase domain.
  • To elucidate the molecular mechanisms underlying the increased enzymatic activity and TKI insensitivity of these EGFR mutants.

Main Methods:

  • Utilized molecular dynamics (MD) simulations to model wild-type EGFR and EGFR variants with exon 20 insertions (V769insASV, D770insNPG).
  • Analyzed both active and inactive conformations to assess local and global structural alterations.
  • Focused on key structural elements including the αC helix, Lys745-Glu762 salt bridge, DFG-motif, R-spine, and P-loop.

Main Results:

  • EGFR exon 20 insertions stabilize the active conformation by enhancing interactions that stabilize the αC helix.
  • The mutations preserve the Lys745-Glu762 salt bridge and the DFG-motif/R-spine in a conformation conducive to activity.
  • Insertions alter the P-loop structure near the ATP-binding pocket and disrupt the Ala767-Arg776 interaction crucial for the inactive state, promoting transition to the active state.

Conclusions:

  • EGFR exon 20 insertions confer distinct structural and dynamic properties compared to wild-type EGFR.
  • These alterations promote a more stable active conformation and hinder the formation of the inactive state, contributing to oncogenesis.
  • The structural changes, particularly near the ATP-binding site, provide a mechanistic basis for the observed clinical resistance to TKIs in NSCLC patients with EGFR exon 20 insertions.